Immune checkpoint inhibitors alone vs immune checkpoint inhibitors—combined chemotherapy for NSCLC patients with high PD-L1 expression: a network meta-analysis

BACKGROUND: We indirectly compared the effects of immune checkpoint inhibitors alone (ICI) and ICI-combined chemotherapy (chemo-ICI) in patients with non-small cell lung cancer who had high programmed death-ligand 1 (PD-L1) expression (defined as tumour proportion score ≥50% or TC3/IC3) through netw...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yimin, Han, Hedong, Zhang, Fang, Lv, Tangfeng, Zhan, Ping, Ye, Mingxiang, Song, Yong, Liu, Hongbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427994/
https://www.ncbi.nlm.nih.gov/pubmed/35641819
http://dx.doi.org/10.1038/s41416-022-01832-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427994/
https://www.ncbi.nlm.nih.gov/pubmed/35641819
http://dx.doi.org/10.1038/s41416-022-01832-4

Ejemplares similares